Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

34.74 +1.72 (+5.21%)
Official Closing Price Updated: 4:10 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 Next >
Enovis to Host Second Quarter 2025 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
Assessing Enovis: Insights From 4 Financial Analysts
Via Benzinga
3 Unprofitable Stocks with Open Questions
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Topics Artificial Intelligence
3 Value Stocks with Questionable Fundamentals
Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few... 
Via StockStory
Earnings Scheduled For May 8, 2025
Via Benzinga
Entegris, Herc, Enovis, Commercial Vehicle Group, and DexCom Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.4%, S&P 500 +1.0%) on hopes the reported ceasefire between Israel and Iran will hold. This de-escalation... 
Via StockStory
Topics Economy Government Stocks
3 Stocks Under $50 in Hot Water
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and... 
Via StockStory
1 Growth Stock to Target This Week and 2 to Be Wary Of
Growth boosts valuation multiples, but it doesn’t always last forever. Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who... 
Via StockStory
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
3 Out-of-Favor Stocks in the Doghouse
Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value... 
Via StockStory
American Airlines, Omnicell, Integra LifeSciences, Enovis, and Warby Parker Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports,... 
Via StockStory
Topics Government Stocks World Trade
Medical Devices & Supplies - Specialty Stocks Q1 Highlights: Enovis (NYSE:ENOV)
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV) and its peers. 
Via StockStory
3 Small-Cap Stocks with Bad Fundamentals
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Topics Supply Chain
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
Where Enovis Stands With Analysts
Via Benzinga
Enovis (NYSE:ENOV) Posts Q1 Sales In Line With Estimates But Stock Drops
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 8.3% year on year to $558.8 million. The company’s full-year revenue... 
Via StockStory
Enovis Announces First Quarter 2025 Results
From Enovis Corporation
Via GlobeNewswire
Enovis (ENOV) Q1 Earnings Report Preview: What To Look For
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting results tomorrow before market hours. Here’s what to look for. 
Via StockStory
3 Dawdling Stocks in Hot Water
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
1 Unprofitable Stock with Competitive Advantages and 2 to Question
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
Reasons to Sell ENOV and 1 Stock to Buy Instead
What a brutal six months it’s been for Enovis. The stock has dropped 22.5% and now trades at $31.96, rattling many shareholders. This might have investors contemplating their next move. 
Via StockStory
Topics Economy Government World Trade
Enovis to Host First Quarter 2025 Results Conference Call on May 8th
From Enovis Corporation
Via GlobeNewswire
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Think Twice About
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,... 
Via StockStory
Spotting Winners: STAAR Surgical (NASDAQ:STAA) And Medical Devices & Supplies - Specialty Stocks In Q4
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including STAAR Surgical (NASDAQ:STAA) and its peers. 
Via StockStory
Medical Devices & Supplies - Specialty Stocks Q4 Teardown: Integer Holdings (NYSE:ITGR) Vs The Rest
Let’s dig into the relative performance of Integer Holdings (NYSE:ITGR) and its peers as we unravel the now-completed Q4 medical devices & supplies - specialty earnings season. 
Via StockStory
Q4 Earnings Roundup: Bausch + Lomb (NYSE:BLCO) And The Rest Of The Medical Devices & Supplies - Specialty Segment
Looking back on medical devices & supplies - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Bausch + Lomb (NYSE:BLCO) and its peers. 
Via StockStory
Enovis Announces Appointment of Damien McDonald as Chief Executive Officer
From Enovis Corporation
Via GlobeNewswire
2 Healthcare Stocks with Solid Fundamentals and 1 to Turn Down
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Enovis™ to Exhibit Extensive Range of Foot & Ankle Solutions at ACFAS 2025
Alongside an evidence-based portfolio, Enovis will showcase how it’s “Redefining Every Step” with confidence-building education and a partnership that goes beyond the product; attendees invited to... 
From Enovis Corporation
Via GlobeNewswire
3 Stocks Under $50 in the Doghouse
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some... 
Via StockStory
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.